Gentian Diagnostics ASA reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was NOK 37.47 million compared to NOK 27.91 million a year ago. Revenue was NOK 37.8 million compared to NOK 30.87 million a year ago. Net loss was NOK 9.79 million compared to NOK 4.63 million a year ago. Basic loss per share from continuing operations was NOK 0.64 compared to NOK 0.3 a year ago.
For the full year, sales was NOK 135.15 million compared to NOK 101.64 million a year ago. Revenue was NOK 142.35 million compared to NOK 111.92 million a year ago. Net loss was NOK 10.36 million compared to NOK 23.62 million a year ago.